Announcements Trials

Browse Landscape

Phase

Phase NA 12 Phase 4 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

fludarabine 17 Cyclophosphamide 16 Positron Emission Tomography Computed Tomography 4 Oncolytic Virotherapy 4 Metformin 4 68Ga-pentixafor 4 lenvatinib 3 Radiosurgery 3 Pemetrexed 3 Paclitaxel 3 Melphalan 3 Immunotherapy, Adoptive 3 Gemcitabine 3 Cholestanetriol 26-Monooxygenase 3 Carboplatin 3 68Ga-NOTA-RM26 3 toripalimab 2 sintilimab 2 pembrolizumab 2 gallium Ga 68 dotatate 2 gallium 68 PSMA-11 2 fludarabine phosphate 2 alpha-Synuclein 2 Progesterone 2 Nivolumab 2 Neoadjuvant Therapy 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 Influenza Vaccines 2 Fluorodeoxyglucose F18 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Unknown × Ropivacaine × Clear all

NCT02719795 2017-02-17

PNBCP

First Affiliated Hospital Xi'an Jiaotong University

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡